new post
StocksRunner logo
mail
search
 
menu
 
Laboratory Corporati
$286.47
-0.92%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

LH Stock Analysis & IQ Rating | Laboratory Corporati

 
 

LH

 

Laboratory Corporati

$286.47

 
-$2.65 | -0.92%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$293.72
 
 
MKT CAP
$23.61B
 
52W Low
$209.38
 
 
VOL
$441.65K
 
P/E Ratio
N/A
 
 
AVG VOL
$781.44K
 
RSI
59.07
 
 
TREND
Sideways
 
 
 

LH Stock IQ

 
lock  Login to see Laboratory Corporati (LH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

LH Target Price

 
 
 

Strengths

 
 

LH Rewards

 Earnings are forecast to grow

LH Rewards

 Trading below its fair value

LH Rewards

 Outperform the market

 
 

LH Price Performance

 
 

$276.16   (+3.73%)

$261.48   (+9.56%)

$279.78   (+2.39%)

$234.21   (+22.31%)

 
 
1year
6month
3month
1month

LH Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

Momentum

×

Momentum

LH Momentum Analysis Has been gaining momentum

Activity

×

Activity

Future

×

Future

LH Future Sentiment Earnings are forecast to grow
LH Future Sentiment Trading below its fair value
LH Future Sentiment Outperform the market
LH Analysts Opinion

LH Analysts opinion is negative and it remained unchanged from the past 3 months

LH Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

93%
Consensus Rating
NA
Buy
Opinion
NA
Trend
Score
50%
Potential
Score
LH Street Sentiment

LH Street Sentiment is extremely bullish but have mixed views on the near-term outlook

LH Risk Level

LH has Low risk level

LH Risk Level
Low
LOW
HIGH

LH Performance Sentiment

Sentiments overview associated with events and the stock performance

93%
Positive
25 out of 27
events present
7%
Negative
2 out of 27
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$251.81
Resistance Price
$289.89
Current Price Range
$286.47
$251.81
$289.89
Show methods +
 
LH Latest Analysis +
 
 
FAQ About LH Stock Insights
 

What is LH current stock price?

What are LH stock strengths?

What is LH Risk Level?

What is LH market cap and volume?

What is LH current Stock IQ?

Should I buy LH stock right now?

Is LH a Strong Buy right now?

What does a 'Strong Buy' rating mean for LH?

What does a 'Strong Sell' rating mean for LH?

What factors influence LH's Stock IQ?

 
 
StocksRunner

Explore our LH Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored LH Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our LH Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

LH

 

Laboratory Corporati

 
Set Alerts
 
 

Current Price

 

$286.47

 
-$2.65 | -0.92%
 
 
52W High
$293.72
 
 
MKT CAP
$23.61B
 
52W Low
$209.38
 
 
VOL
$441.65K
 
P/E Ratio
N/A
 
 
AVG VOL
$781.44K
 
RSI
59.07
 
 
TREND
Sideways
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

LH Price Performance

 
 

$276.16   (+3.73%)

$261.48   (+9.56%)

$279.78   (+2.39%)

$234.21   (+22.31%)

 
 
1year
6month
3month
1month
 

LH Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

Momentum

×

Momentum

LH Momentum Sentiment Has been gaining momentum

Activity

×

Activity

Future

×

Future

LH Future Sentiment Earnings are forecast to grow
LH Future Sentiment Trading below its fair value
LH Future Sentiment Outperform the market
LH Analysts Opinion

LH Analysts opinion is negative and it remained unchanged from the past 3 months

LH Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

93%
Consensus Rating
NA
Buy
Opinion
NA
Trend
Score
50%
Potential
Score
LH Street Sentiment

LH Street Sentiment is extremely bullish but have mixed views on the near-term outlook

LH Risk Level

LH has Low risk level

LH Risk Level
Low
LOW
HIGH
LH Performance Sentiment
Sentiments overview associated with events and the stock performance.
93%
Positive
25 out of 27
events present
7%
Negative
2 out of 27
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$251.81
Resistance Price
$289.89
Current Price Range
$286.47
$251.81
$289.89
Show methods +
 
 
 
 

LH Stock IQ

 
 
 
lock  Login to unlock Laboratory Corporati (LH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

LH Rewards

 Earnings are forecast to grow

LH Rewards

 Trading below its fair value

LH Rewards

 Outperform the market

 
 
 

LH Latest Analysis

 
 
 

Why did Health Canada approve sunscreens tied to fake lab data? #health. What regulators confirmed Health Canada has acknowledged that it approved sunscreen products whose efficacy dossiers relied on testing from a laboratory later implicated in fabricating results. The agency told CBC News that some approvals were granted using efficacy data produced by that lab and

 

Mon Mar 2, 2026

$286.47 | -0.92%
 
Activity

Could anti‑aging polyamines promote cancer? #science. A double‑edged molecule: aging benefit versus cancer risk New laboratory research has shown that small molecules long associated with cellular health and longevity can also support tumour growth under certain conditions. Polyamines — naturally occurring compounds involved in DNA stabilization

 

Wed Feb 25, 2026

$282.78 | -1.51%
 
Activity

CVKD: Phase 2 HIT Results Show Encouraging Reduction in Thrombotic Events. By David Bautz PhDNASDAQ:CVKDREAD THE FULL CVKD RESEARCH REPORTBusiness UpdateEncouraging Results from Phase 2 HIT TrialOn February 24 2026 Cadrenal Therapeutics Inc. (NASDAQ:CVKD) announced encouraging results from the Phase 2 trial of CAD-1005 (formerly CAD-1005) in heparin-induced thrombocytopenia (HIT). The results showed a meaningful reduction in thrombotic events despite not meeting the studys primary endpoint of p

 

Wed Feb 25, 2026

$282.78 | -1.51%
 
Activity

Were Not Working On Dinosaurs Theres No Dino DNA: Colossal Biosciences CEO On De-Extinction.

Credit: Anna Tutova (Founder AI Crypto Minds) with Ben Lamm (co-Founder &. CEO Colossal Biosciences) at World Governments Summit in Dubai.We'.re not working on dinosaurs there'.s no dino DNA. That makes some people sad makes some people happy. &. Ben Lamm Co-Founder &. CEO Colossal BiosciencesWhen you walk into Dubai'.s Museum of the Future this year you mig

 

Tue Feb 24, 2026

$287.13 | +0.63%
 
Activity

Canada Nickel and the University of Texas Successfully Complete Carbon Sequestration Pilot at the Crawford Nickel Project. Highlights:In-situ carbon injection pilot successfully sequesters 12 tonnes of CO2 at the Crawford Nickel ProjectProject demonstrates another permanent CO2 storage pathway distinct from the and processesTORONTOFeb. 19 2026Canada Nickel Company Inc. (".Canada Nickel". or the ".Company".) (TSXV:) (OTCQB: CNIKF) is pleased to announce the successful completion of

 

Thu Feb 19, 2026

$282.40 | +1.23%
 
Activity

Liberty Defense Secures Contract with Acclaimed Infectious Disease Laboratory for HEXWAVE™ Walkthrough Screening System. HEXWAVEs Advanced Millimeter-Wave & AI Screening System will Be Utilized to Screen Employees and Visitors at the Laboratory

 

Wed Feb 18, 2026

$278.76 | +0.76%
 
Activity

Zero Candida Scales Production to 250 ISO 13485 Clinical-Grade Prototypes of ZC-001 Therapeutic Device. Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 womenVANCOUVER BCFeb. 17 2026 (TSXV:) (OTCQB:) (FSE: 9L2) (the ".Company". or ".ZCT".) a FemTech medical device company advancing next-generation solutions for women'.s health today announced that it is scaling manufacturing to 250 clinical-grade prototypes of its ZC-001 therapeutic device under

 

Tue Feb 17, 2026

$276.67 | -2.11%
 
Activity
Potential
 
 
 
 
 
StocksRunner

Discover LH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LH. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our LH Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LH Stock trends

LH Stock performance

LH Stock analysis

LH investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

LH Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing LH

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing LH

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.